Free tool
D-Mannose vs Cranberry for UTIs: Evidence Decoder
Cranberry products have the more consistent evidence: reviews link them to fewer repeat UTIs in women with recurrent infections. D-mannose is less certain: the largest placebo-controlled trial, at 2 g a day, found no benefit. Neither treats an active UTI, so see a clinician for burning, fever or back pain.
How to use it
- Find the ingredient and its amount on your product's Supplement Facts label.
- Read across the matching rows below to see what was studied, at what dose, and what was found.
- Compare your product's amount with the dose in the trials; a much smaller amount is not what those trials tested.
- Talk to a clinician before relying on either for repeat UTIs, and get care promptly for UTI symptoms, fever, back pain or any symptom in pregnancy.
Reference
| Evidence | Who was studied | Dose studied | What it found |
|---|---|---|---|
| D-mannose: 2024 placebo-controlled trial, the largest to date | 598 women with recurrent UTI in UK primary care | 2 g of D-mannose powder a day for 6 months | No reduction in recurrent UTIs: 51.0% vs 55.7% on placebo. |
| D-mannose: 2014 trial with no placebo arm | 308 women with recurrent UTI | 2 g a day for 6 months | Fewer recurrences (14.6%) than no prophylaxis (60.8%); open-label, so weaker evidence. |
| D-mannose: 2022 Cochrane review | 7 trials, 719 adults | From 200 mg up to 2 to 3 g a day | Too little high-quality evidence to support or refute D-mannose for preventing or treating UTIs. |
| D-mannose: 2025 meta-analysis | 6 trials, 1167 participants | Varied | No significant reduction in recurrent UTIs. |
| Cranberry: 2023 Cochrane review | 50 trials, 8857 participants | Varied juice, tablets and capsules | Probably fewer symptomatic UTIs in women with recurrent UTIs (RR 0.74); not in pregnant women or older adults in care. |
| Cranberry: 2024 meta-analysis of PAC dose | 10 trials that reported daily PAC intake | At least 36 mg of PAC a day, compared with less | Lower UTI risk only when daily PAC intake was at least 36 mg (RR 0.82). |
| Cranberry: 2024 network meta-analysis | 20 trials, 3091 participants | Juice, tablets and other liquids | Cranberry juice was linked to fewer UTIs than placebo liquid; juice results do not automatically apply to capsules. |
| Either one, for an infection that has already started | NIH (NCCIH) and ACOG guidance | Not applicable | Cranberry is not recommended as a treatment for an existing UTI. Antibiotics are used to treat UTIs. |
Dose matters
The main D-mannose trials used 2 g a day. A product with a much smaller amount is not what those trials tested, so their results, positive or null, do not carry over to it.
About combined blends
Some supplements, including Balance Complex, hold cranberry and D-mannose together in one small blend, with the split not stated on the label. The amount is far below the 2 g of D-mannose used in trials, and the trial results do not apply to it.
Cranberry and PACs
NIH explains that proanthocyanidins (PACs) in cranberry are thought to stop bacteria sticking to the bladder wall. One 2024 analysis saw lower risk only at 36 mg of PAC a day or more, and many labels do not state PAC content.
When not to wait
Pain or burning when peeing, blood in urine, fever, chills, back or side pain, or any UTI symptom in pregnancy needs a clinician promptly. Supplements are not a substitute for testing or antibiotics.
How this tool works
This is a fixed reference built from peer-reviewed reviews and trials in the Balance Complex evidence vault, plus NIH and ACOG guidance. Each row states who was studied, the dose used and the result, including trials that found no benefit. It has no inputs and does not recommend a dose or a product.
Frequently asked questions
Does D-mannose work for UTIs?
The evidence is mixed. Early small trials looked positive, but the largest placebo-controlled trial (598 women, 2024) found 2 g of D-mannose daily did not reduce recurrent UTIs: 51.0% vs 55.7% on placebo. A 2022 Cochrane review found too little high-quality evidence either way.
Does cranberry juice help with a UTI?
Not as a treatment. NIH says cranberry is not recommended for treating an existing UTI, and antibiotics are used for that. For repeat UTIs, a 2023 Cochrane review found cranberry products probably reduce symptomatic UTIs in women with recurrent UTIs, but not in pregnant women or older adults in care.
How much D-mannose was used in studies?
The key trials used 2 g of D-mannose powder a day for 6 months, and earlier studies ranged from 200 mg up to 2 to 3 g a day. This page does not recommend a dose; ask your clinician or pharmacist what suits you.
Is cranberry or D-mannose better for recurrent UTIs?
Cranberry has more and larger trials behind it, mainly in women with recurrent UTIs. D-mannose results are inconsistent, and the biggest placebo-controlled trial found no benefit. A 2025 network meta-analysis ranked both among non-antibiotic options, so ask a clinician which, if either, fits you.
Does D-mannose have side effects?
In the 2014 trial, D-mannose had fewer side effects than a daily preventive antibiotic, and a 2020 meta-analysis noted diarrhea in 8 of 103 people taking it. Ask a clinician or pharmacist before starting, especially if you are pregnant, nursing or take other medicines.
Can I take cranberry if I am on warfarin?
NIH reports conflicting evidence on whether cranberry interacts with the blood thinner warfarin. If you take warfarin or any other medicine, talk with your clinician or pharmacist before using cranberry products or other herbal supplements.
Is cranberry safe during pregnancy?
NIH says cranberry in amounts commonly found in food appears safe in pregnancy and breastfeeding, but the evidence for larger amounts is not conclusive. Reviews also found little or no UTI benefit in pregnant women. Any UTI symptom in pregnancy needs a clinician right away.
Sources
- Hayward et al., 2024, d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial (PubMed 38587819)
- Kranjcec et al., 2014, D-mannose powder for prophylaxis of recurrent urinary tract infections in women (PubMed 23633128)
- Cooper et al., 2022, D-mannose for preventing and treating urinary tract infections, Cochrane review (PubMed 36041061)
- Vargas et al., 2025, Efficacy of D-mannose as prophylaxis of recurrent urinary tract infection, meta-analysis (PubMed 41004704)
- Lenger et al., 2020, D-mannose vs other agents for recurrent urinary tract infection prevention, meta-analysis (PubMed 32497610)
- Williams et al., 2023, Cranberries for preventing urinary tract infections, Cochrane review (PubMed 37068952)
- Xiong et al., 2024, Cranberries with high dose of proanthocyanidins and urinary tract infections, meta-analysis (PubMed 39668896)
- Moro et al., 2024, Cranberry juice, cranberry tablets, or liquid therapies for urinary tract infection, network meta-analysis (PubMed 39030132)
- Han et al., 2025, Nonantibiotic prophylaxis for urinary tract infections, network meta-analysis (PubMed 39095666)
- NCCIH (NIH): Cranberry, usefulness and safety
- ACOG: Urinary Tract Infections
- CDC: Urinary Tract Infection Basics
This tool gives general information for adults and does not diagnose or treat any condition. It is not a substitute for advice from a clinician. If you have severe symptoms, fever, or are pregnant, contact a healthcare professional.